期刊
CURRENT PHARMACEUTICAL DESIGN
卷 27, 期 20, 页码 2344-2365出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612827666210303141416
关键词
Breast cancer; omics; genes; diagnosis; biomarkers; therapy
资金
- Deanship of Scientific Research at Princess Nourahbint Abdulrahman University through the Fasttrack Research Funding Program
Breast cancer is described as the most prevalent lifethreatening cancer in women, causing thousands of deaths annually worldwide. This review aims to explore the pathogenesis and treatment options of breast cancer, with the goal of providing effective therapeutic solutions.
Breast cancer has been described as the most prevalent lifethreatening cancer in women. Worldwide, breast cancer causes more than 50,000 deaths annually, accounting for 18% of all women deaths [1-4]. A recent publication has estimated that approximately 80% of women diagnosed with breast cancer each year are aged > 45. In the USA, the health burden of breast cancer is increasing at a drastic rate, with 232,240 newly diagnosed patients and A silent monster, breast cancer, is a challenging medical task for researchers. Breast cancer is a lead-ing cause of death in women with respect to other cancers. A case of breast cancer is diagnosed among women every 19 seconds, and every 74 seconds, a woman dies of breast cancer somewhere in the world. Several risk factors, such as genetic and environmental factors, favor breast cancer development. This review tends to pro-vide deep insights regarding the genetics of breast cancer along with multiple diagnostic and therapeutic ap-proaches as problem-solving negotiators to prevent the progression of breast cancer. This assembled data main-ly aims to discuss omics-based approaches to provide enthralling diagnostic biomarkers and emerging novel therapies to combat breast cancer. This review article intends to pave a new path for the discovery of effective treatment options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据